Here’s a roundup of some of Wednesday’s major pharmaceutical news: An FDA panel gave Human Genome Sciences a boost with a thumbs-up for its lupus drug, Benlysta; Merck’s experimental heart drug appears to work well without side…
The “new normal” coined by Pimco posits a long era of diminished earnings and stock prices as overleveraged consumers and companies cut back. But it’s not playing out that way. It seems Corporate America is growing less and les…
Employers who used job cuts to save money during the economic crisis knew that layoffs would put strains on the workers who remained. But now, those cost-cutting measures are impairing their ability to attract the top talent th…